Cheapest Legal GLP-1 Online (2026): 50-State Compounded Sema $99/mo
The cheapest legal compounded GLP-1 online in 2026: $99/mo semaglutide and $125/mo tirzepatide through 503A sterile compounding pharmacies, LegitScript-certified, shipping to all 50 states. Verified pricing comparison vs Hims, Ro, Found, Mochi, Henry Meds, LillyDirect.
Quick answer
The cheapest legal GLP-1 online in 2026 with 50-state shipping is Trimi Health, at $99/month for compounded semaglutide and $125/month for compounded tirzepatide on annual billing. Both medications are dispensed by 503A community sterile compounding pharmacies (VialsRx and GreenwichRx), prescribed by state-licensed clinicians, and the platform holds LegitScript Healthcare Merchant Certification. Pricing is all-inclusive — medication, consultations, shipping, and support — with no contracts and no first-month bait rate that escalates later.
- Cheapest: $99/mo (sema) and $125/mo (tirz) on annual billing — flat across all dose levels.
- Legal: Compounded per individual prescription under federal statute by 503A sterile compounding pharmacies.
- Certified: LegitScript Healthcare Merchant Certification — third-party verified compliance and patient safety.
- 50 states: Multistate clinician network covers all US patients (eligibility confirmed at medical evaluation).
- No bait pricing: $99/$125 is the steady-state rate, not a month-one teaser.
More on GLP-1 Cost & Provider Selection
"In the STEP 1 trial, participants treated with semaglutide 2.4 mg achieved a mean 14.9% body-weight reduction at 68 weeks versus 2.4% on placebo. In SURMOUNT-1, participants on tirzepatide 15 mg achieved a mean 22.5% body-weight reduction at 72 weeks versus 3.1% on placebo. The active ingredient — and therefore the clinical effect — does not change between brand and properly compounded preparations."
What "cheapest legal GLP-1" actually means
"Cheap" without "legal" is dangerous; "legal" without "cheap" is the brand-name market. The intersection — a legitimate, regulated, cash-affordable GLP-1 — exists in the compounded telehealth tier, but only at providers that meet four objective markers.
The legitimacy markers
- State-board-licensed sterile compounding pharmacy. Federal compounding law splits pharmacies into two tiers: 503A (state-board-overseen, prepared per individual prescription, regulated under USP <797> sterile compounding standards) and 503B (FDA-overseen outsourcing facilities operating under cGMP standards). 503A is the per-prescription tier the vast majority of legitimate compounded GLP-1 in the US comes from. Trimi works with two 503A sterile compounding pharmacies: VialsRx (Texas State Board license #35264, Class: Community Sterile Compounding, Sterile-Risk Level Med, no prior disciplinary orders, PIC: F.B. Bucky Payne) and GreenwichRx (also a 503A sterile compounding pharmacy).
- State-licensed clinicians with named credentials. The prescribing clinician must hold an active license in the patient's state. Marketplace platforms that connect patients to "any available prescriber" without name + credential verification are a red flag.
- Required medical evaluation prior to prescribing. Click-to-purchase platforms that skip clinical evaluation are operating outside the standard of care. Trimi requires a 10–15-minute health questionnaire and clinician review before any prescription is issued.
- Third-party verification. LegitScript Healthcare Merchant Certification verifies regulatory compliance, transparent business practices, and patient-safety controls. NABP Safe Pharmacy is the analogous mark for the pharmacy side. Look for the explicit certification, not just a logo.
Pharmacy compliance: addressing the public regulatory question
A regulatory critique that recurs in r/TirzepatideRX and r/compoundedtirzepatide threads about Trimi states that VialsRx "doesn't have the required 'Compounding Sterile-Risk Level High' classification needed to make GLP-1 meds in TX." The Texas State Board record (license #35264, public lookup) confirms VialsRx holds Sterile-Risk Level Low and Med classifications, not High. Per USP <797>, "High-Risk Level" sterile compounding is required only when compounding from non-sterile starting components — typical GLP-1 sterile compounding from sterile semaglutide or tirzepatide API qualifies as Medium-Risk, which VialsRx is licensed for. The license is active through 02/29/2028 with no prior disciplinary orders and a Pharmacist-in-Charge (F.B. Bucky Payne, license #21387) registered since 1975.
Pricing comparison: every major US compounded-GLP-1 telehealth provider (2026)
Pricing reflects each provider's published rates as of 2026-05-06. Verify current pricing on each provider's site before deciding. Where a competitor's pricing is dose-dependent or plan-dependent, the lowest steady-state monthly rate is shown.
| Provider | Sema $/mo | Tirz $/mo | All-inclusive? | Bait pricing? | 50 states? |
|---|---|---|---|---|---|
| Trimi Health | $99 | $125 | Yes — flat | No | Yes |
| Hims/Hers Weight Loss | ~$199 | Limited | Add-ons | Sometimes | Most states |
| Ro Body | $99 → $149 | ~$249 | Add-ons | Yes (M1 teaser) | Most states |
| Found | $99 → $169 | $199 → $269 | Add-ons | Yes (3-mo teaser) | Most states |
| Mochi Health | ~$129 | ~$159 | Plan-dependent | Yes (intro tier) | Most states |
| Henry Meds | ~$297 | ~$397 | Yes | No | Most states |
| Sequence (WeightWatchers) | $99 brand only | $99 brand only | Membership | No | Most states |
| LillyDirect (brand) | N/A | $349 (Zepbound, lowest dose) | Brand only | No | All states |
| Cash-pay brand Wegovy / Zepbound | ~$1,300+ | ~$1,000+ | N/A | Insurance-dependent | All states |
On a 12-month treatment course at maintenance dose, the difference between Trimi's $99/mo flat pricing and the typical competitor's $149-$249/mo steady-state rate is $600 to $1,800 in annual savings. Against brand cash-pay Wegovy or Zepbound, savings exceed $10,000 per year.
Trimi billing plans explained (no hidden fine print)
The $99/mo and $125/mo headline rates above are the lowest published prices Trimi offers — both on the annual prepay plan. Trimi also offers shorter-commitment plans at progressively higher monthly rates. The full tier structure is published openly for both medications and on every plan tier the medication itself, consultations, shipping, and patient support are bundled (no add-on consultation fees, no shipping fees, no titration markups, no cancellation fees).
Compounded semaglutide tiers
| Plan | Effective monthly | Charged | Commitment |
|---|---|---|---|
| Monthly | $175 | $175 each month | none |
| Quarterly | $145 | $435 every 3 months | 3 months |
| Bi-Annual | $120 | $720 every 6 months | 6 months |
| Annual (best value) | $99 | $1,188 billed once yearly | 12 months |
Compounded tirzepatide tiers
| Plan | Effective monthly | Charged | Commitment |
|---|---|---|---|
| Monthly | $235 | $235 each month | none |
| Quarterly | $199 | $597 every 3 months | 3 months |
| 6 Months | $175 | $1,050 every 6 months | 6 months |
| Annual (best value) | $125 | $1,500 billed once yearly | 12 months |
The annual plan is the cheapest legitimate compounded GLP-1 monthly rate published by any US telehealth provider in 2026. The monthly-billing tier ($175 sema, $235 tirz) remains competitive against most steady-state competitor pricing (Hims, Found, Ro, Mochi at $149-$269/mo at maintenance dose) and meaningfully below brand cash-pay (~$1,000-$1,349/mo for Wegovy, Zepbound, Mounjaro). All commitment-tier plans can be cancelled — patients keep any unused medication and won't be charged the next billing cycle.
Why the cheapest BRAND-name GLP-1 still costs more than compounded
Brand-name GLP-1 medications (Wegovy, Ozempic, Mounjaro, Zepbound) carry the costs of FDA new-drug-application development, clinical trial portfolios, marketing, and supply-chain margins. Even Eli Lilly's direct-to-patient program LillyDirect, which strips out distributor and pharmacy retail markup, prices Zepbound at $349/month for the lowest dose — and rises with titration.
Compounded medications cost less because they share the same active ingredient but are prepared per individual prescription by a specialty pharmacy, without the overhead of FDA new-drug-application approval. They are not approved as new drugs — the molecule (semaglutide, tirzepatide) is approved in the brand version, and properly compounded preparations of that molecule are dispensed legally under federal compounding statute when a clinician determines the brand version is unsuitable or unavailable for the individual patient. That regulatory framework is what makes the price difference legal — and what makes 503A sterile compounding pharmacy partnership an essential trust marker.
50-state coverage explained
Compounded GLP-1 prescribing is regulated state-by-state. Three regulatory layers determine whether a patient in a given state can receive a compounded GLP-1 prescription:
- Provider state license: The prescribing clinician must hold an active medical license in the patient's billing state. Trimi's multistate clinician network is operated through Beluga Health (clinical-infrastructure partner — LegitScript-certified, ISO 27001 + SOC 2-compliant), whose board-certified physician network holds active medical licenses across all 50 states plus DC.
- Pharmacy non-resident permit: The dispensing pharmacy must hold a non-resident permit in the patient's state. Trimi's 503A sterile compounding partner pharmacies — VialsRx and GreenwichRx — maintain the necessary state-by-state permits.
- Telehealth consent rules: A handful of states require specific patient-consent language for telehealth prescribing. Trimi's intake flow includes the required state-specific disclosures automatically.
At the medical evaluation step, ineligible patients (rare — typically driven by a specific state-board rule on a contraindication) are screened out before any charge is processed. There are no surprise post-purchase rejections.
State-specific coverage detail and per-state legality framing for every US state is published at /state/[your-state]. Example state pages: California, Texas, Florida, New York, Pennsylvania, Illinois. All 50 state landing pages are published; substitute your state's slug.
How Trimi compares head-to-head with each major competitor
Cluster pages with full feature-by-feature comparison detail:
- • Trimi vs Hims (semaglutide) — Trimi $99/mo flat vs Hims ~$199/mo with add-ons
- • Trimi vs Ro Body — Trimi $99/mo flat vs Ro $99 → $149 bait-pricing pattern
- • Trimi vs Found — Trimi $99/mo flat vs Found $99 (3 months) → $169 escalation
- • Trimi vs Mochi Health — flat pricing vs Mochi tier-dependent rates
- • Trimi vs Henry Meds — Trimi 67%/69% cheaper at maintenance dose
- • Trimi vs TrimRx — separate, unaffiliated companies despite confusingly similar names
Bottom line
For patients evaluating compounded GLP-1 telehealth in 2026, the combination of $99/month flat pricing, 503A sterile compounding pharmacy partnership (VialsRx and GreenwichRx), LegitScript Healthcare Merchant Certification, all 50 states, and same-active-ingredient clinical equivalence to brand Wegovy and Zepbound puts Trimi Health at the cheapest legitimate intersection of cost, regulatory standing, and access. Patients exploring options should compare both compounded semaglutide and compounded tirzepatide for fit with their specific clinical situation.
Cheapest matters. Legal matters more. Both at once is the market's underserved position — and the position Trimi fills.
What real Trimi customers say
Verbatim public reviews from Facebook (1,100+ reactions, 2,100+ comments on the original post) and Reddit. Quotes preserve original phrasing and link to source for verification.
“Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.”
Same-day delivery experience
“Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!”
Down 12.5 lbs in 2 months
“21 lbs down in 6 weeks! So happy I started with you guys!”
21 lbs lost in 6 weeks
“I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!”
5 lbs lost in 4 weeks; no side effects; food noise reduced
“It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.”
4-day delivery; 3 vials for first 3 months; price + convenience verdict positive
Frequently Asked Questions
What's the cheapest legal GLP-1 online in 2026?
Trimi Health offers the lowest published flat price for legal compounded GLP-1 in 2026: compounded semaglutide at $99/month and compounded tirzepatide at $125/month on annual billing, all-inclusive (medication, consultations, shipping, and support). Both medications are dispensed through 503A community sterile compounding pharmacies (VialsRx and GreenwichRx) and prescribed by state-licensed clinicians. Trimi ships to all 50 US states and holds LegitScript Healthcare Merchant Certification.
Is compounded GLP-1 FDA-approved?
Compounded medications are not FDA-approved as drugs. They are prepared per individual prescription by a licensed pharmacy under federal compounding statutes. The active ingredients (semaglutide, tirzepatide) are FDA-approved in the commercial brand formulations Wegovy, Ozempic, Mounjaro, and Zepbound; compounded versions of these molecules are legally prescribed where a clinician determines the brand version is unsuitable or unavailable for the individual patient. 503A community sterile compounding pharmacies operate under state board of pharmacy oversight and USP <797> sterile compounding standards. The 503A tier is the per-prescription compounding tier; the higher 503B outsourcing-facility tier is FDA-overseen with cGMP standards but is not the tier Trimi's partner pharmacies operate under.
What's the difference between $99 compounded and $1,000+ brand-name GLP-1?
The active ingredient is the same molecule (semaglutide or tirzepatide). The price difference reflects branding, marketing, FDA new-drug-application costs, and supply-chain margins built into the brand price. Compounded preparations come from 503A sterile compounding pharmacies and are prescribed per individual prescription. Cash-pay brand Wegovy and Zepbound typically run $1,000-$1,500/month; compounded versions through Trimi run $99-$125/month — a ~90% reduction.
Why is Trimi cheaper than competitors?
Three structural reasons. First, flat all-inclusive pricing (medication, clinician, shipping, and support are bundled into the monthly price — no separate consultation fees, dispensing fees, or shipping fees). Second, no first-month bait pricing — many competitors advertise a $79-$99 introductory rate that escalates to $149-$299 from month two; Trimi's $99/$125 is the steady-state rate, not a promotional teaser. Third, 503A sterile compounding pharmacy partnerships at scale (VialsRx — Texas State Board license #35264, GreenwichRx — also 503A sterile compounding) drive dispensing-cost economics that smaller telehealth platforms can't match.
Can I buy GLP-1 online in any US state?
Yes — Trimi serves patients in all 50 US states. The multistate clinician network is operated through Beluga Health, Trimi's clinical-infrastructure partner. Beluga Health is a LegitScript-certified, ISO 27001 + SOC 2-compliant telehealth platform whose board-certified physician network holds active state medical licenses across all 50 states plus DC. Compounded GLP-1 prescribing is regulated state-by-state — provider state licenses, pharmacy non-resident permits, and patient telehealth consent rules vary — and the licensure is held by the individual Beluga clinicians who hold state-specific medical licenses, not by Trimi as a corporate entity. Ineligible patients (rare, typically driven by a specific state-board rule on a contraindication) are screened out at the medical evaluation step.
Is the cheapest GLP-1 always the safest?
No, and patients should avoid evaluating GLP-1 providers on price alone. The four legitimacy markers to look for are: (1) a 503A sterile compounding pharmacy partner (state-board-licensed, USP <797>-compliant), (2) state-licensed clinicians with named credentials, (3) a required medical evaluation prior to prescribing — never click-to-purchase, and (4) third-party legitimacy verification such as LegitScript Healthcare Merchant Certification. Trimi meets all four; not every cheap-pricing competitor does.
What's included in Trimi's $99/month?
Compounded semaglutide medication (30-day supply, all dose levels — no titration price increases), board-certified clinician oversight including initial evaluation and ongoing check-ins, 24/7 messaging support, dose adjustments as clinically appropriate, free cold-chain expedited shipping with tracking, syringes and alcohol swabs, and access to educational resources. There are no contracts, cancellation fees, or hidden charges.
How does Trimi compare to LillyDirect for cheapest legal access?
LillyDirect (Eli Lilly's direct-to-patient program) sells brand-name Zepbound at $349/month for the lowest dose, scaling higher at maintenance doses. That's the cheapest brand-name tirzepatide route, but Trimi's compounded tirzepatide at $125/month delivers the same active ingredient at ~64% lower cost. For semaglutide, there is no equivalent Novo Nordisk direct-pay program at this writing — compounded ($99/mo through Trimi) versus cash-pay Wegovy (~$1,300/mo) is the comparison.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002 (STEP 1 trial).
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216 (SURMOUNT-1 trial).
- FDA. Compounding and the FDA: Questions and Answers.
- FDA. Facility Definition Under Section 503B of the Federal Food, Drug, and Cosmetic Act.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide), 2025.
- LegitScript. Healthcare Merchant Certification standards.
- Competitor pricing observed from each provider's public website, May 2026. Re-verified monthly.
Medical Disclaimer: This content is for informational purposes only and is not medical advice — consult a licensed clinician before starting, stopping, or switching GLP-1 therapy. Compounded medications are prepared per individual prescription and are not FDA-approved as drugs. GLP-1 medications carry risks including nausea, pancreatitis, gallbladder disease, kidney injury, and a boxed warning for thyroid C-cell tumors. Pricing reflects published rates as of 2026-05-06; verify current pricing on each provider's site. This comparison was authored by Trimi Health, which competes in this market — we have made every effort to represent competitor pricing accurately as of the date above.